SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-071066
Filing Date
2023-12-18
Accepted
2023-12-18 16:00:09
Documents
12
Period of Report
2023-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K meip-20231218.htm   iXBRL 8-K 61794
  Complete submission text file 0000950170-23-071066.txt   176059

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20231218_lab.xml EX-101.LAB 12798
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20231218.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20231218_pre.xml EX-101.PRE 9455
6 EXTRACTED XBRL INSTANCE DOCUMENT meip-20231218_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 231493634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)